LTRNLantern Pharma Inc.Nov 13, 2025Q3 2025
Read transcript →Lantern Pharma Inc. (LTRN) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.20
-10.77%
Mkt Cap $29.86M
LTRNLantern Pharma Inc.Nov 13, 2025LTRNLantern Pharma Inc.May 15, 2025Q1 2025
Read transcript →LTRNLantern Pharma Inc.Mar 27, 2025Q4 2024
Read transcript →LTRNLantern Pharma Inc.Nov 8, 2024Q3 2024
Read transcript →LTRNLantern Pharma Inc.May 9, 2024Q1 2024
Read transcript →LTRNLantern Pharma Inc.Mar 18, 2024Q4 2023
Read transcript →LTRNLantern Pharma Inc.Nov 9, 2023Q3 2023
Read transcript →LTRNLantern Pharma Inc.Aug 9, 2023Q2 2023
Read transcript →LTRNLantern Pharma Inc.May 13, 2023Q1 2023
Read transcript →LTRNLantern Pharma Inc.Mar 20, 2023Q4 2022
Read transcript →LTRNLantern Pharma Inc.Nov 7, 2022Q3 2022
Read transcript →LTRNLantern Pharma Inc.Aug 8, 2022Q2 2022
Read transcript →LTRNLantern Pharma Inc.May 3, 2022Q1 2022
Read transcript →LTRNLantern Pharma Inc.Mar 10, 2022Q4 2021
Read transcript →LTRNLantern Pharma Inc.Nov 1, 2021Q3 2021
Read transcript →LTRNLantern Pharma Inc.Jul 31, 2021Q2 2021
Read transcript →LTRNLantern Pharma Inc.May 4, 2021Q1 2021
Read transcript →LTRNLantern Pharma Inc.Mar 10, 2021Q4 2020
Read transcript →LTRNLantern Pharma Inc.Oct 30, 2020Q3 2020
Read transcript →LTRNLantern Pharma Inc.Jul 30, 2020Q2 2020
Read transcript →